Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 140
Filter
1.
Exp Clin Endocrinol Diabetes ; 120(3): 139-44, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22068616

ABSTRACT

BACKGROUND: Angiopoietin-like protein 4 (Angptl4) is thought to cause an increase in serum triglyceride levels. In the present study, we elucidated Angptl4 expression in the mouse models of type 1 and type 2 diabetes mellitus, and investigated the possible mechanisms involved. METHODS: Type 1 diabetes was induced in C57BL/6 J mice by treating them with streptozotocin (STZ). Type 2 diabetes was induced by feeding the mice a high-fat diet (HFD) for 18 weeks. RESULTS: The levels of Angptl4 mRNA expression in liver, white adipose tissue (WAT), and brown adipose tissue (BAT) were found to increase in the STZ diabetic mice relative to control mice. This effect was attenuated by insulin administration. In the HFD diabetic mice, the Angptl4 mRNA expression levels were increased in liver, WAT, and BAT. Treatment with metformin for 4 weeks attenuated the increased levels of Angptl4 mRNA. Fatty acids (FAs) such as palmitate and linoleate induced Angptl4 mRNA expression in H4IIE hepatoma cells and 3T3-L1 adipocytes. Treatment with insulin but not metformin attenuated FA-induced Angptl4 mRNA expression in H4IIE. Both insulin and metformin did not influence the effect of FAs in 3T3-L1 cells. CONCLUSION: These observations demonstrated that Angptl4 mRNA expression was increased through the elevated free FAs in diabetic mice.


Subject(s)
Angiopoietins/genetics , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/metabolism , Fatty Acids, Nonesterified/metabolism , Insulin/metabolism , 3T3-L1 Cells , Angiopoietin-Like Protein 4 , Angiopoietins/metabolism , Animals , Cell Line, Tumor , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/etiology , Diet, High-Fat , Down-Regulation/drug effects , Fatty Acids, Nonesterified/blood , Fatty Acids, Nonesterified/pharmacology , Gene Expression Regulation/drug effects , Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Male , Metformin/pharmacology , Mice , Mice, Inbred C57BL , Rats , Signal Transduction/drug effects , Signal Transduction/genetics , Streptozocin , Up-Regulation/drug effects , Up-Regulation/genetics
2.
Neuroscience ; 176: 188-98, 2011 Mar 10.
Article in English | MEDLINE | ID: mdl-21145948

ABSTRACT

Peripheral neuropathy has been reported to prevail in obese or pre-diabetic individuals, yet its etiology remains unknown. Palmitate, a saturated fatty acid increased in obesity and diabetes, is known to induce apoptosis in multiple types of cells and this effect may be mediated by ceramide, a member of the sphingolipid family. To clarify whether de novo ceramide synthesis from palmitate contributes to apoptosis of Schwann cells, we cultured immortalized mouse Schwann cells (IMS) and rat primary Schwann cells with palmitate, a ceramide analogue C2-ceramide as well as inhibitors of the de novo ceramide synthesis (myriocin and fumonisin B1). Apoptosis of IMS detected by nuclear staining and cell membrane inversion was significantly increased by incubation with palmitate for 48 h in a dose-dependent fashion. This enhanced apoptosis was partially but significantly suppressed by myriocin and fumonisin B1. Western blot analysis and immunostaining revealed that palmitate clearly activated caspase-3 in IMS. Unexpectedly, the ceramide synthesis inhibitors failed to suppress the palmitate-induced caspase-3 activation in spite of complete restoration in ceramide accumulation. The results seemed relevant to the observations that C2-ceramide did not activate caspase-3 while provoking apoptosis with a clear dose-dependency. In agreement, the pro-apoptotic action of C2-ceramide was not attenuated by caspase inhibitors that partially suppressed palmitate-induced apoptosis. These results in IMS were well reproducible in rat primary Schwann cells, indicating that the observed phenomena are not specific to the cell line. Collectively, we have reached a conclusion that palmitate induces apoptosis in Schwann cells via both a ceramide-mediated, caspase-3-independent pathway and ceramide-independent, caspase-3-dependent pathways. Given the fact that palmitate and ceramide are increased in obese or pre-diabetic subjects, these lipids may be implicated in the pathogenesis of peripheral neuropathy observed in these disorders.


Subject(s)
Apoptosis/physiology , Ceramides/metabolism , Palmitates/toxicity , Schwann Cells/pathology , Signal Transduction/physiology , Animals , Apoptosis/drug effects , Blotting, Western , Cells, Cultured , Diabetic Neuropathies/metabolism , Fluorescent Antibody Technique , Mice , Obesity/complications , Obesity/metabolism , Palmitates/metabolism , Peripheral Nervous System Diseases/etiology , Peripheral Nervous System Diseases/metabolism , Rats , Reverse Transcriptase Polymerase Chain Reaction , Schwann Cells/drug effects , Schwann Cells/metabolism , Signal Transduction/drug effects
3.
Exp Clin Endocrinol Diabetes ; 118(10): 692-8, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20533175

ABSTRACT

BACKGROUND: Hedgehog (Hh) signaling plays an important role in pancreas development. However, its role in the developed endocrine pancreas remains to be elucidated. To clarify whether Hh signaling participates in beta-cell survival, we investigated the role of Hh signaling in cytokine-induced apoptosis in pancreatic beta-cells. METHODS: Insulin-producing INS-1E cells were transfected with Sonic Hh (Shh) expression vector or siRNA against Indian Hh (siIhh). The Hh signal inhibitor cyclopamine were pretreated in INS-1E cells and rat islets. The cells were exposed to 200 U/ml IL-1ß and 200 U/ml IFN-γ for 48 h. Apoptosis was estimated by flow cytometory and immunofluorescence staining for cleaved caspase-3. Nitric oxide generation was measured by Griess reaction. RESULTS: We found that exposure to proinflammatory cytokines increased Ihh expression in rat islets and INS-1E cells. Overexpression of Shh reduced cytokine-induced apoptosis. By contrast, treatment with cyclopamine increased cytokine-induced apoptosis in INS-1E cells and rat islets. Treatment with the siIhh showed same results in INS-1E cells. Forced expression of Shh suppressed cytokine-induced nuclear factor-κB promoter activity, leading to attenuation of nitric oxide synthase 2 expression and nitric oxide production, while Ihh knockdown enhanced this pathway in INS-1E cells. CONCLUSION: Our findings suggest that Hh signaling is implicated in protecting beta-cells from cytokine-induced cytotoxicity.


Subject(s)
Cytokines/immunology , Hedgehog Proteins/metabolism , Insulin-Secreting Cells/metabolism , Signal Transduction/physiology , Animals , Apoptosis/drug effects , Cell Line , Diabetes Mellitus, Type 1/immunology , Gene Expression Regulation/drug effects , Gene Silencing , Hedgehog Proteins/genetics , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/pathology , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Islets of Langerhans/pathology , Male , NF-kappa B/genetics , NF-kappa B/metabolism , Nitric Oxide Synthase Type II/metabolism , Organ Culture Techniques , RNA, Messenger/metabolism , RNA, Small Interfering , Rats , Signal Transduction/drug effects , Veratrum Alkaloids/pharmacology
4.
J Endocrinol Invest ; 27(2): 167-70, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15129813

ABSTRACT

X-linked nephrogenic diabetes insipidus (NDI) is a rare inherited disorder caused by mutations in the arginine vasopressin receptor 2 (V2R) gene. The clinical phenotype is fully expressed in hemizygous male patients and is usually asymptomatic in heterozygous females. In the present study, a 51-yr-old Japanese female with congenital NDI and her family members were examined. The patient developed severe hypernatremia accompanied by hypoosmotic polyuria after gynecological surgery, and was unable to concentrate urinary osmolality in response to exogenous vasopressin. Direct sequencing analysis of the propositus and her two affected sons revealed a two-nucleotide deletion change at codon 30 (g.452-453delAC) in the V2R gene, resulting in a frameshift and premature termination in translation at codon 190. The X chromosome inactivation pattern was investigated in the propositus using methylation analysis of the polymorphic CAG repeat in the androgen receptor gene, and the value for relative X chromosome inactivation of one allele was 70.2%. In conclusion, we identified a novel V2R gene mutation in a female patient and her sons with congenital NDI, and her phenotype may be caused by skewed X chromosome inactivation.


Subject(s)
Chromosomes, Human, X , Diabetes Insipidus, Nephrogenic/genetics , Gene Deletion , Gene Silencing , Receptors, Vasopressin/genetics , Female , Humans , Male , Middle Aged , Mutation , Pedigree , Phenotype
5.
J Endocrinol ; 173(1): 23-33, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11927381

ABSTRACT

Prolonged exposure of tissues to a receptor agonist often leads to adaptive changes that limit the subsequent responsiveness of the tissue to the same agonist. Recently, we have generated rats transgenic for the metallothionein I-human arginine vasopressin (AVP) fusion gene (Tg), which produced high plasma AVP with relatively preserved renal water excretion, suggesting that there might be adaptive mechanism(s) for maintaining water and electrolyte homeostasis against chronic AVP oversecretion from the earliest stage of life. In this study, to investigate whether down-regulation of AVP V2 receptor (V2R), which could possibly be caused by long-standing high plasma AVP, participates in this adaptive mechanism(s), non-peptidic V2R antagonist OPC31260 was administered to reverse the down-regulation, and water loading was performed after V2R antagonist treatment had been withdrawn. Additionally, to confirm the down-regulation, Northern blotting analysis for V2R mRNA was carried out. Tg rats showed slightly decreased urine volume and water intake with an equivalent plasma [Na(+)] level (Tg 140.4 +/- 0.6 mEq/l; control 139.3 +/- 0.6 mEq/l) under basal conditions. After water loading using a liquid diet containing zinc, which stimulates the promoter region in the transgene, the urine increase showed only limited suppression with a dramatically increased plasma AVP level and mild hyponatremia (135.8 +/- 1.8 mEq/l) in Tg rats. When diet containing OPC31260 had been provided for 4 days until the day before the start of water loading, antidiuresis and hyponatremia (125.4 +/- 1.mEq/l) were significantly potentiated. V2R mRNA expression in kidney was significantly less in Tg rats than in control rats under basal conditions, and this suppression was restored by OPC31260 treatment to levels comparable with those of control rats. These results suggest that long-standing high plasma AVP causes V2R down-regulation, and it may play an important role in the adaptive mechanism(s) for maintaining water and electrolyte homeostasis in chronically AVP-overexpressing rats.


Subject(s)
Adaptation, Physiological , Arginine Vasopressin/blood , Body Water/metabolism , Kidney/metabolism , Receptors, Vasopressin/metabolism , Animals , Animals, Genetically Modified , Antidiuretic Hormone Receptor Antagonists , Arginine Vasopressin/administration & dosage , Arginine Vasopressin/genetics , Benzazepines/pharmacology , Blotting, Northern/methods , Homeostasis , Humans , Kidney/chemistry , Kidney/drug effects , Male , Metallothionein/genetics , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Receptors, Vasopressin/genetics , Recombinant Fusion Proteins/metabolism , Sodium/metabolism , Zinc/administration & dosage
6.
J Endocrinol ; 173(1): 35-44, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11927382

ABSTRACT

Arginine vasopressin (AVP) is a major antidiuretic hormone, the overproduction of which causes diluting hyponatremia in humans and is called the syndrome of inappropriate antidiuresis (SIAD). To study physiological changes resulting from AVP overproduction and to develop an animal model of hyponatremia, the human AVP gene was expressed under the control of the metallothionein promoter in transgenic (Tg) rats. Analyses of AVP immunoreactivity (irAVP) in the tissues revealed that the transgene is expressed mainly in the central nervous system. Gel filtration showed that irAVP in the brain and plasma was properly processed AVP. AVP purified from the brains of both Tg and control rats also exerted equal bioactivity to generate cAMP in LLC-PK1 cells. The founder rats did not show any physical or anatomical abnormalities. Under basal conditions, Tg rats had high plasma AVP levels (Tg 13.8 +/- 2.5 pg/ml; control 2.7 +/- 1.2 pg/ml; n=6 in both groups; means +/- S.E.M.), decreased urine volume, and normal plasma [Na(+)]. Hypertonic saline injected i.p. did not affect AVP secretion in Tg rats. In response to a zinc-supplemented liquid diet, plasma AVP decreased in control rats, but increased in Tg rats (Tg 32.7 +/- 2.7 pg/ml; control 1.0+/-0.1 pg/ml; n=6), resulting in hyponatremia (Tg 135.2 +/- 2.5 mEq/l; control 140.8 +/- 0.4 mEq/l; n=6). To our knowledge, this is the first transgenic animal to show diluting hyponatremia. This transgenic rat may therefore provide a useful model in which to investigate various physiological alterations resulting from the oversecretion of AVP which involve SIAD, stress response, behavior, and blood pressure.


Subject(s)
Arginine Vasopressin/metabolism , Hyponatremia/metabolism , Inappropriate ADH Syndrome/metabolism , Models, Animal , Animals , Animals, Genetically Modified , Arginine Vasopressin/analysis , Brain Chemistry , Humans , Male , Metallothionein/genetics , Rats , Rats, Sprague-Dawley , Recombinant Fusion Proteins/metabolism , Zinc/administration & dosage
7.
Plant Cell ; 13(9): 2085-98, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11549765

ABSTRACT

The rice KNOX protein OSH15 consists of four conserved domains: the MEINOX domain, which can be divided into two subdomains (KNOX1 and KNOX2); the GSE domain; the ELK domain; and the homeodomain (HD). To investigate the function of each domain, we generated 10 truncated proteins with deletions in the conserved domains and four proteins with mutations in the conserved amino acids in the HD. Transgenic analysis suggested that KNOX2 and HD are essential for inducing the abnormal phenotype and that the KNOX1 and ELK domains affect phenotype severity. We also found that both KNOX2 and HD are necessary for homodimerization and that only HD is needed for binding of OSH15 to its target sequence. Transactivation studies suggested that both the KNOX1 and ELK domains play a role in suppressing target gene expression. On the basis of these findings, we propose that overproduced OSH15 probably acts as a dimer and may ectopically suppress the expression of target genes that induce abnormal morphology in transgenic plants.


Subject(s)
Conserved Sequence , Homeodomain Proteins/chemistry , Homeodomain Proteins/metabolism , Oryza , Amino Acid Sequence , Cell Nucleus/metabolism , DNA/metabolism , Dimerization , Electrophoretic Mobility Shift Assay , Gene Expression Regulation, Plant , Homeodomain Proteins/genetics , Molecular Sequence Data , Morphogenesis , Mutation/genetics , Nuclear Proteins/chemistry , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Oryza/chemistry , Oryza/cytology , Oryza/genetics , Oryza/growth & development , Phenotype , Plant Leaves/chemistry , Plant Leaves/cytology , Plant Leaves/genetics , Plant Leaves/growth & development , Plant Proteins/chemistry , Plant Proteins/genetics , Plant Proteins/metabolism , Plants, Genetically Modified , Protein Binding , Protein Structure, Quaternary , Protein Structure, Tertiary , Protein Transport , Structure-Activity Relationship , Transcription Factors/chemistry , Transcription Factors/genetics , Transcription Factors/metabolism , Two-Hybrid System Techniques
8.
Jpn J Clin Oncol ; 31(2): 61-4, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11302343

ABSTRACT

BACKGROUND: A recently identified mismatch repair gene, hMLH3, contains two simple repeat sequence regions, (A)9 and (A)8, in its coding region. To clarify the role of hMLH3 in hereditary nonpolyposis colorectal cancer (HNPCC), we searched for hMLH3 somatic and germline mutations, particularly in the repeat regions, in 41 HNPCC patient cells. METHODS: We analyzed the hMLH3 (A)9 and (A)8 repeats in 27 colorectal cancers with microsatellite instability (MSI) as well as in normal cells from 41 HNPCC patients by means of polymerase chain reaction-single-strand conformation polymorphism. hMSH3 (A)8 and hMSH6 (C)8 repeats were also examined in these cancers. RESULTS: Frameshift mutations in the hMLH3 (A)9 repeat were observed in 4/27 (14.8%) cancers with MSI, all of which showed the severe MSI phenotype. No mutations in the (A)8 repeat were found in any case. The mutation frequency of the hMLH3 (A)9 repeat was similar to that of the hMSH6 (C)8 repeat (5/26, 19.2%), but was significantly lower than that of the hMSH3 (A)8 repeat (16/27, 59.3%) (P < 0.001). All four cancers with hMLH3 mutations exhibited germline hMSH2 and/or somatic hMSH3 mutations. No germline mutation in the hMLH3 (A)9 or (A)8 repeat was detected in normal cells from the 41 HNPCC patients. CONCLUSION: hMLH3 mutations were infrequently observed in HNPCC cancers with MSI and they may be secondary to other mismatch repair gene mutations. Hence hMLH3 may only play a small role in HNPCC tumorigenesis.


Subject(s)
Carrier Proteins/genetics , Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , Frameshift Mutation , Adult , Female , Humans , Microsatellite Repeats , Middle Aged , MutL Proteins
9.
Gan To Kagaku Ryoho ; 28(3): 387-90, 2001 Mar.
Article in Japanese | MEDLINE | ID: mdl-11265410

ABSTRACT

UNLABELLED: Gastric cancers that produce alpha feto protein (AFP) usually have a poor prognosis. We report an AFP-producing gastric cancer that showed a partial response to low-dose CPT-11 and low-dose cisplatin combination chemotherapy. AFP-producing gastric cancers successfully treated with chemotherapy have been reported, but to our knowledge this is the first report of successful treatment with low-dose CPT-11 and low-dose cisplatin combination chemotherapy. CASE: A 49 year-old woman who had gastric cardiac cancer with esophageal invasion was admitted to our institution. Since AFP-positive cells were demonstrated immunohistochemically in biopsy specimens and levels of AFP in serum were high, AFP-producing cancer was diagnosed. Because of metastasis to Virchow's node and the paraaortic lymph nodes, the tumor was considered unresectable. The patient's poor general condition necessitated chemotherapy with low toxicity and high efficacy. She was treated with low-dose CPT-11 and low-dose cisplatin combination chemotherapy. After two cycles of this treatment, the tumor volume and the serum levels of AFP had decreased markedly. The only side effect of the treatment was leukopenia.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Camptothecin/analogs & derivatives , Stomach Neoplasms/drug therapy , alpha-Fetoproteins/biosynthesis , Antineoplastic Agents/administration & dosage , Antineoplastic Agents, Phytogenic/administration & dosage , Camptothecin/administration & dosage , Cisplatin/administration & dosage , Female , Humans , Irinotecan , Middle Aged
10.
Biochem Biophys Res Commun ; 278(1): 211-6, 2000 Nov 11.
Article in English | MEDLINE | ID: mdl-11071874

ABSTRACT

Type 1 diabetes mellitus is an autoimmune disease resulting from apoptotic destruction of pancreatic beta-cells. The activation of inducible nitric oxide synthase (iNOS) by inflammatory cytokines is considered a mediator of destruction in beta-cells. Recent findings showed that the neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP), whose distribution was identified in pancreatic neurons, inhibited nitric oxide (NO) production in cytokine-activated macrophages. In the present study, we investigated the cytoprotective effect of PACAP in the cytokine-exposed mice beta-cell line, beta TC cells. 1 x 10(-8) M PACAP inhibited the reduction of cell viability, NO production, expression of iNOS mRNA, and iNOS promoter activity caused by the combination of three proinflammatory cytokines. Selective iNOS inhibitor also showed the cytoprotective effect in beta TC cells. These data suggested that PACAP has a cytoprotective effect in cytokine-treated beta-cells through inhibition of iNOS transcription.


Subject(s)
Cytokines/metabolism , Neuropeptides/metabolism , Nitric Oxide Synthase/antagonists & inhibitors , Cell Line , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Humans , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Islets of Langerhans/metabolism , Luciferases/metabolism , Macrophages/enzymology , Macrophages/metabolism , Neuropeptides/pharmacology , Nitric Oxide/metabolism , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Pituitary Adenylate Cyclase-Activating Polypeptide , Promoter Regions, Genetic , Recombinant Proteins/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Transcription, Genetic , Transfection , Tumor Necrosis Factor-alpha/pharmacology , omega-N-Methylarginine/pharmacology
11.
Cancer Chemother Pharmacol ; 46(3): 180-4, 2000.
Article in English | MEDLINE | ID: mdl-11021734

ABSTRACT

PURPOSE: When oral anticancer agents are used for adjuvant chemotherapy of colorectal cancer, compliance and feasibility become issues because of the long treatment time. Appropriate studies of these issues are lacking. We investigated compliance and feasibility during a weekday-on/weekend-off schedule of oral UFT (uracil-tegafur) over a period of 1 year administered as adjuvant chemotherapy to patients with colorectal cancer. PATIENTS AND METHODS: A UFT dose of 600 mg/day was prescribed according to a weekday-on/weekend-off schedule to 87 patients after potentially curative resection. Compliance was investigated in three ways: physician interview, patient self-report, and chemical analysis of urine. The results were compared with the dose prescribed. Feasibility was evaluated on the basis of two indices: relative performance (RP), which was the ratio of the actual total dose taken to the total dose planned, and individual dose intensity (IDI), which was the ratio of the actual dose taken to the dose planned during a given period. RESULTS: The compliance assessed by physician interview and by patient self-report conformed well with the prescribed dose, the rate of agreement among the three compliance measures being more than 94%. Chemical analysis of urine in 38 of the patients revealed that they were actually taking the drug. The RP was 0.72, and the IDI was 0.8. CONCLUSION: From these results, the feasibility of the weekday-on/weekend-off schedule was judged to be good. It is suggested that the feasibility would be even better if the dose of UFT was set according to body surface area.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Colorectal Neoplasms/drug therapy , Administration, Oral , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Chemotherapy, Adjuvant , Colorectal Neoplasms/surgery , Drug Administration Schedule , Feasibility Studies , Female , Humans , Male , Middle Aged , Patient Compliance , Tegafur/administration & dosage , Tegafur/adverse effects , Uracil/administration & dosage , Uracil/adverse effects
12.
J Hepatobiliary Pancreat Surg ; 7(3): 252-9, 2000.
Article in English | MEDLINE | ID: mdl-10982623

ABSTRACT

The efficacy and safety of microwave coagulation therapy (MCT) in patients with hepatocellular carcinoma (HCC) and impaired hepatic reserve were studied. Preoperative background factors, postoperative results, and prognostic factors were compared in 51 patients who underwent hepatic resection (HR group) and 38 patients who underwent microwave coagulation therapy (MCT group). Before surgery, measures of hepatic function, including level of albumin (P = 0.0072), prothrombin time (P<0.0001), hepaplastin test (P = 0.0088), and the radioactivity of technetium-99m galactosyl-human serum albumin 15 min in the liver after injection divided by that in both liver and heart (P <0.0001) were significantly lower in the MCT group than in the HR group. The indocyanine green dye retention rate at 15 min was significantly greater (P<0.0001) in the MCT group than in the HR group, and a significant difference was noted in Child-Pugh grade between the groups (P<0.0001). Operative time (P = 0.0014) and blood loss during surgery (P = 0.0005) were significantly lower in the MCT group than in the HR group. In contrast, no significant differences were recognized between the groups in the changes in postoperative liver function, or in the rates of morbidity, mortality, local recurrence, and survival. Moreover, the type of treatment (HR or MCT) was not a prognostic factor. The results indicate that MCT can be used safely as an alternative to hepatic resection in patients with poor liver function without reducing the efficacy of local control.


Subject(s)
Carcinoma, Hepatocellular/surgery , Electrocoagulation/methods , Laparotomy/methods , Liver Neoplasms/surgery , Microwaves/therapeutic use , Aged , Carcinoma, Hepatocellular/diagnostic imaging , Carcinoma, Hepatocellular/mortality , Female , Follow-Up Studies , Humans , Liver Function Tests , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/mortality , Male , Middle Aged , Multivariate Analysis , Probability , Proportional Hazards Models , Survival Rate , Tomography, X-Ray Computed , Treatment Outcome
13.
Appl Microbiol Biotechnol ; 54(1): 59-68, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10952006

ABSTRACT

A glutaminase from Aspergillus oryzae was purified and its molecular weight was determined to be 82,091 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Purified glutaminase catalysed the hydrolysis not only of L-glutamine but also of D-glutamine. Both the molecular weight and the substrate specificity of this glutaminase were different from those reported previously [Yano et al. (1998) J Ferment Technol 66: 137-143]. On the basis of its internal amino acid sequences, we have isolated and characterized the glutaminase gene (gtaA) from A. oryzae. The gtaA gene had an open reading frame coding for 690 amino acid residues, including a signal peptide of 20 amino acid residues and a mature protein of 670 amino acid residues. In the 5'-flanking region of the gene, there were three putative CreAp binding sequences and one putative AreAp binding sequence. The gtaA structural gene was introduced into A. oryzae NS4 and a marked increase in activity was detected in comparison with the control strain. The gtaA gene was also isolated from Aspergillus nidulans on the basis of the determined nucleotide sequence of the gtaA gene from A. oryzae.


Subject(s)
Aspergillus oryzae/genetics , Glutaminase/genetics , Amino Acid Sequence , Aspergillus oryzae/enzymology , Bacteriophage lambda/genetics , Base Sequence , Cloning, Molecular , DNA, Complementary , DNA, Fungal , Molecular Sequence Data , Reverse Transcriptase Polymerase Chain Reaction
14.
Mol Carcinog ; 28(3): 184-8, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10942535

ABSTRACT

CDX2 is a tumor-suppressor homeobox gene involved in colon carcinogenesis, but its role in gastric cancer is unknown. Although GATA4, -5 and, -6 transcription factors have distinct functions in the regulation of gastrointestinal epithelial cell differentiation, there have been no reports regarding GATA4/5/6 alterations in gastrointestinal carcinomas. By using a semiquantitative reverse transcription-polymerase chain reaction assay, we studied the expression of gut development-related genes CDX2/1 and GATA4/5/6 in 11 human gastric cancer cell lines. The expression of CDX2 appeared to progressively decrease with the transition from well differentiated to poorly differentiated cancer cell lines. CDX1 was below detectable levels in all cell lines. The expression of GATA4 and GATA5 was undetectable in four and six cell lines, respectively, whereas the majority of the cell lines expressed GATA6 abundantly. These results suggest that CDX2 and GATA4/5 may be associated with the carcinogenesis of the stomach. Mol. Carcinog. 28:184-188, 2000.


Subject(s)
Adenocarcinoma/pathology , Avian Proteins , DNA-Binding Proteins/biosynthesis , Gene Expression Regulation, Neoplastic , Homeodomain Proteins/biosynthesis , Neoplasm Proteins/biosynthesis , Stomach Neoplasms/pathology , Transcription Factors/biosynthesis , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , CDX2 Transcription Factor , Cell Differentiation/genetics , Cell Transformation, Neoplastic/genetics , DNA-Binding Proteins/genetics , GATA4 Transcription Factor , GATA5 Transcription Factor , Homeodomain Proteins/genetics , Humans , Immunoenzyme Techniques , Neoplasm Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism , Transcription Factors/genetics
15.
Cancer Lett ; 157(2): 185-91, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-10936679

ABSTRACT

To clarify the roles of the adenomatous polyposis coli (APC) and beta-catenin genes in hereditary nonpolyposis colorectal cancer (HNPCC) tumorigenesis, we searched for their mutations in 14 HNPCC adenomas with microsatellite instability (MSI). Seven (50%) adenomas exhibited somatic APC mutations, five of which were frameshift mutations and the other two nonsense ones. However, the APC mutational spectrum of these adenomas was similar to that of sporadic colorectal tumors. Two adenomas (14.3%) with undetectable APC alterations showed missense mutations at codon 45 (TCT to TTT or to CCT) in beta-catenin. The MSI frequency in adenomas with beta-catenin mutations was significantly higher than that with APCones (P<0.001), indicating that mutations of beta-catenin rather than APC are strongly associated with MSI. These data suggest that adenomas with beta-catenin activating mutations and some with APC inactivating mutations may be precursors of HNPCC colorectal cancers.


Subject(s)
Adenoma/genetics , Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , Cytoskeletal Proteins/genetics , Frameshift Mutation , Genes, APC/genetics , Mutation, Missense , Trans-Activators , Asian People/genetics , Colorectal Neoplasms/genetics , DNA, Neoplasm/analysis , Humans , Japan , Microsatellite Repeats , Polymerase Chain Reaction , beta Catenin
16.
Eur J Surg ; 166(2): 112-8, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10724487

ABSTRACT

OBJECTIVE: To find out whether an increased rate of portal venous blood flow after oral intake of glucose could be used to estimate liver function. DESIGN: Prospective study. SETTING: University hospital, Japan. SUBJECTS: Sixty patients, of whom 23 had hepatocellular carcinoma and liver cirrhosis, 21 had tumours metastatic to normal liver, and 16 had obstructive jaundice treated with percutaneous transhepatic biliary drainage (PTBD). INTERVENTION: Portal flow was measured after oral intake of glucose 75 g using pulsed-Doppler ultrasonography. RESULTS: The ratio of portal flow 30 minutes after glucose intake to that before intake (PVFR30) was significantly lower in cirrhotic patients than in those with metastases and a normal liver. A PVFR30 of less than 1.5 indicated impaired hepatic function assessed by the Child-Pugh scores, indocyanine green clearance test, prothrombin time, and hepaplastin test. It also indicated less reduction in total bilirubin concentrations in the first week after PTBD. CONCLUSIONS: Results suggest that PVFR30 can be used to estimate liver function and predict outcome after PTBD.


Subject(s)
Cholestasis, Intrahepatic/physiopathology , Glucose , Liver Circulation/physiology , Liver Cirrhosis/physiopathology , Liver Neoplasms/physiopathology , Administration, Oral , Adult , Aged , Aged, 80 and over , Blood Flow Velocity , Cholestasis, Intrahepatic/diagnostic imaging , Female , Glucose/administration & dosage , Humans , Liver Cirrhosis/diagnostic imaging , Liver Function Tests , Liver Neoplasms/blood supply , Liver Neoplasms/diagnostic imaging , Male , Middle Aged , Ultrasonography, Doppler
17.
Eur J Surg ; 166(1): 77-84, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10688222

ABSTRACT

OBJECTIVE: To find out if N-acetylcysteine (NAC) would improve hepatic circulation in dogs with obstructive jaundice. DESIGN: Open laboratory study. SETTING: University hospitals, Japan and France. MATERIALS: 14 male beagle dogs and 10 male Wistar rats. INTERVENTIONS: Obstructive jaundice was produced by ligation of the common bile duct (CBD) for 7 days in both dogs and rats. Either 5% dextrose (control group, n = 7) or NAC (NAC group, n = 7) was given to dogs. Sinusoidal endothelial cells were obtained from rats after ligation by elutriation, and varying amounts of NAC were given. MAIN OUTCOME MEASURES: The volumes of portal blood flow and hepatic microcirculatory tissue flow were reduced after ligation of the CBD, but those increased after NAC had been given to dogs with obstructive jaundice. NAC increased the concentrations of plasma cyclic 3',5'-guanosine monophosphate (cGMP). It also increased concentrations of serum and hepatic-reduced glutathione, and hepatic adenosine triphosphate (ATP) in cholestatic dogs, and secretion of cGMP from sinusoidal endothelial cells from rats with obstructive jaundice. CONCLUSION: These results suggest that NAC given intravenously effectively improves hepatic circulation and hepatic function in dogs with obstructive jaundice.


Subject(s)
Acetylcysteine/pharmacology , Cholestasis/physiopathology , Liver Circulation/drug effects , Portal Vein/physiopathology , Adenosine Triphosphate/metabolism , Animals , Common Bile Duct/surgery , Cyclic GMP/blood , Dogs , Glutathione/metabolism , Ligation , Liver/metabolism , Male , Microcirculation/drug effects , Rats , Rats, Wistar , Regional Blood Flow/drug effects , Stimulation, Chemical
18.
Am J Physiol Endocrinol Metab ; 278(2): E189-94, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10662701

ABSTRACT

Polydipsic mice, STR/N, which show extreme polydipsia and polyuria, were discovered in 1958. In the STR/N, urine outputs are much higher than in control mice. The possibility of an abnormal regulation of the arginine vasopressin (AVP) system, or an abnormality in the renal susceptibility to AVP, should be considered. In this study we investigated the AVP system and water regulation in STR/N. We sequenced the AVP and the AVP V(2)-receptor genes of the STR/N by direct sequencing. No mutation was found in either of them. AVP gene expression examined by in situ hybridization and plasma sodium in 8-wk-old STR/N was significantly lower than in control mice, whereas it was significantly higher at 20 wk. Renal sensitivity to injected AVP was attenuated in 20-wk-old STR/N. The suppression of AVP synthesis due to excessive water retention in 8-wk-old STR/N suggests that polydipsia may be the primary cause in this strain. The 20-wk-old STR/N became dehydrated with the acceleration of AVP synthesis, which might have resulted from secondary desensitization to AVP.


Subject(s)
Arginine Vasopressin/physiology , Drinking/genetics , Mutation , Polyuria/genetics , Receptors, Vasopressin/genetics , Water-Electrolyte Balance , Amino Acid Sequence , Animals , Arginine Vasopressin/genetics , Base Sequence , Diuresis , Male , Mice , Mice, Inbred ICR , Mice, Inbred Strains , Molecular Sequence Data , Osmolar Concentration , Polyuria/physiopathology , Receptors, Vasopressin/chemistry , Sodium/blood , Urine , Water Deprivation
19.
Gan To Kagaku Ryoho ; 27(14): 2223-30, 2000 Dec.
Article in Japanese | MEDLINE | ID: mdl-11142166

ABSTRACT

In evaluations of adjuvant chemotherapy with oral anticancer agents, compliance in taking the drug as prescribed (compliance), adverse reactions, and feasibility are important factors in setting the dose. A weekday-on/weekend-off schedule, in which 600 mg/day of UFT was taken for 5 consecutive days and not taken on the following 2 days, was carried out as a postoperative adjuvant chemotherapy for one year in 87 patients with colorectal cancer who had undergone potentially curative resection. The prescribed dose and the dose of ingestion confirmed by physician interview were both highly consistent with the dose of ingestion according to the patients' self reports, with consistency rates of more than 94% for both. Relative performance (RP) yielded a value of 0.72, and individual dose intensity (IDI) yielded 0.8 on average. Female gender, low body weight, and low body surface area were factors that negatively affected feasibility. None of the adverse reactions was serious. Based on the feasibility and adverse reactions, the dosage of UFT should be set according to the body surface area at 375-425 mg/m2/day. When this schedule is used as one arm of a controlled study, it is suggested that the dose should be decided with 400 mg/m2 as a guideline.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Colonic Neoplasms/drug therapy , Rectal Neoplasms/drug therapy , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Colonic Neoplasms/surgery , Drug Administration Schedule , Female , Humans , Male , Middle Aged , Patient Compliance , Rectal Neoplasms/surgery , Tegafur/administration & dosage , Uracil/administration & dosage
20.
Nucleic Acids Res ; 28(1): 97-101, 2000 Jan 01.
Article in English | MEDLINE | ID: mdl-10592192

ABSTRACT

The Rice Genome Research Program (RGP) launched a large-scale rice genome sequencing in 1998 aimed at decoding all genetic information in rice. A new genome database called INE (INtegrated rice genome Explorer) has been developed in order to integrate all the genomic information that has been accumulated so far and to correlate these data with the genome sequence. A web interface based on Java applet provides a rapid viewing capability in the database. The first operational version of the database has been completed which includes a genetic map, a physical map using YAC (Yeast Artificial Chromosome) clones and PAC (P1-derived Artificial Chromosome) contigs. These maps are displayed graphically so that the positional relationships among the mapped markers on each chromosome can be easily resolved. INE incorporates the sequences and annotations of the PAC contig. A site on low quality information ensures that all submitted sequence data comply with the standard for accuracy. As a repository of rice genome sequence, INE will also serve as a common database of all sequence data obtained by collaborating members of the International Rice Genome Sequencing Project (IRGSP). The database can be accessed at http://www. dna.affrc.go.jp:82/giot/INE. html or its mirror site at http://www.staff.or.jp/giot/INE.html


Subject(s)
Databases, Factual , Genome, Plant , Oryza/genetics , Chromosomes, Artificial, Yeast , User-Computer Interface
SELECTION OF CITATIONS
SEARCH DETAIL
...